DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Eagle Pharmaceuticals, Inc. (EGRX)
« Back to company indexEGRX Chatter Timeline
Stock Ticker for EGRX
Most Active Tweeters for EGRX
| User | Tweets |
|---|---|
| @Tickeron | 12 |
| @ConsumerFeed | 7 |
| @ThisLincolnian | 7 |
| @macondailynews | 6 |
| @WeekHerald | 6 |
Recent Tweets for EGRX
 |
@Tickeron $EGRX's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram just turned positive. View odds for this… https://t.co/SAFytyl2t3 October 21st 2019, 7:10pm |
 |
@StockTexts $EGRX Eagle Pharmaceuticals, Inc. SEC Filing: Form 8-K https://t.co/DycnUP9bhg October 21st 2019, 7:10am |
 |
@confcalltran Eagle: Transforming Patient Care By Targeting Best - In - Class Solutions https://t.co/3m1y4KR9pz $EGRX October 21st 2019, 7:10am |
 |
@macondailynews Insider Selling: Eagle Pharmaceuticals Inc $EGRX Director Sells 13,842 Shares of Stock https://t.co/F1fk4TAafr October 21st 2019, 4:10am |
 |
@dakotafinancial Insider Selling: Eagle Pharmaceuticals Inc $EGRX Director Sells $866,232.36 in Stock https://t.co/JQeAgWGjUh October 21st 2019, 4:10am |
 |
@stocknewstimes Eagle Pharmaceuticals $EGRX Downgraded by ValuEngine to “Hold” https://t.co/7DJoiS39Sj October 21st 2019, 2:10am |
 |
@TheMarketsDaily Eagle Pharmaceuticals $EGRX Rating Lowered to Hold at ValuEngine https://t.co/DS0GkhGhHh October 21st 2019, 2:10am |
|
@Tickeron $EGRX's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram crosses above signal line. View odds for… https://t.co/00PSHUBRAq October 20th 2019, 7:10pm |
|
@macondailynews Eagle Pharmaceuticals $EGRX Downgraded by ValuEngine https://t.co/NotTnde8SD October 20th 2019, 1:10pm |
|
@dakotafinancial Eagle Pharmaceuticals $EGRX Downgraded to Hold at ValuEngine https://t.co/awYzrHOprM October 20th 2019, 1:10pm |
 |
@WeekHerald Zacks Investment Research Lowers Eagle Pharmaceuticals $EGRX to Strong Sell https://t.co/5HJGOi8HHl October 20th 2019, 10:10am |
 |
@ThisLincolnian Eagle Pharmaceuticals $EGRX Stock Rating Lowered by Zacks Investment Research https://t.co/lYoNdUcQWL October 20th 2019, 10:10am |
 |
@chaffeybreeze Hudson Executive Capital Lp Sells 13,842 Shares of Eagle Pharmaceuticals Inc $EGRX Stock https://t.co/aTt3xi1vOH #stocks October 20th 2019, 4:10am |
 |
@IRAMarketReport Hudson Executive Capital Lp Sells 13,842 Shares of Eagle Pharmaceuticals Inc $EGRX Stock https://t.co/jmJjujPN9T #markets October 20th 2019, 4:10am |
 |
@ConsumerFeed Hudson Executive Capital Lp Sells 13,842 Shares of Eagle Pharmaceuticals Inc $EGRX Stock https://t.co/pzeUiFMkPP October 20th 2019, 4:10am |
|
@WeekHerald Research Analysts Set Expectations for Eagle Pharmaceuticals Inc’s Q3 2019 Earnings $EGRX https://t.co/MyuHfJWqxs October 20th 2019, 1:10am |
 |
@bbnsnews Research Analysts Set Expectations for Eagle Pharmaceuticals Inc’s Q3 2019 Earnings $EGRX https://t.co/9luG05yV2I October 20th 2019, 1:10am |
|
@Tickeron $EGRX's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram just turned positive. View odds for this… https://t.co/EwSKMrGtZm October 19th 2019, 10:10pm |
|
@TheMarketsDaily Eagle Pharmaceuticals Inc $EGRX Director Hudson Executive Capital Lp Sells 13,842 Shares https://t.co/TmjbwqG88G October 19th 2019, 6:10am |
|
@stocknewstimes Eagle Pharmaceuticals Inc $EGRX Director Hudson Executive Capital Lp Sells 13,842 Shares https://t.co/OdMdLhoIlw October 19th 2019, 6:10am |
|
@Tickeron $EGRX's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram crosses above signal line. View odds for… https://t.co/n2yI1FIbXn October 19th 2019, 1:10am |
|
@ThisLincolnian Eagle Pharmaceuticals Inc to Post Q3 2019 Earnings of $0.08 Per Share, William Blair Forecasts $EGRX https://t.co/lATgy2trbX October 19th 2019, 1:10am |
|
@WeekHerald ValuEngine Lowers Eagle Pharmaceuticals $EGRX to Hold https://t.co/OW3UaWTtO8 October 19th 2019, 1:10am |
|
@ThisLincolnian ValuEngine Lowers Eagle Pharmaceuticals $EGRX to Hold https://t.co/7KvDIbZXXz October 19th 2019, 1:10am |
 |
@insiderbuyings $EGRX new insider selling: 15544 shares. https://t.co/2fJN3JVgN6 October 18th 2019, 8:10pm |
 |
@InsiderAlertsIA $EGRX: New Insider Filing on Director EXECUTIVE CAPITAL LP HUDSON: https://t.co/hSqqzSncYp October 18th 2019, 6:10pm |
 |
@AmericanBanking Eagle Pharmaceuticals Inc $EGRX Director Sells $866,232.36 in Stock https://t.co/eqgYvrgtWs #stocks October 18th 2019, 6:10pm |
 |
@ZolmaxNews Insider Selling: Eagle Pharmaceuticals Inc $EGRX Director Sells 13,842 Shares of Stock https://t.co/XLgTmsXp9J October 18th 2019, 6:10pm |
 |
@dailypoliticaln Eagle Pharmaceuticals Inc $EGRX Director Sells $866,232.36 in Stock https://t.co/w6jTkOlHZi October 18th 2019, 6:10pm |
 |
@fintel_io Insider Braunstein Douglas L reports selling 15,544 shares of $EGRX for a total cost of $972,745.45 [CLICK FOR PR… https://t.co/lU4j0aXbXg October 18th 2019, 5:10pm |
|
@confcalltran Eagle Pharmaceuticals director just disposed of 15,544 shares https://t.co/tidGX4uNKm $EGRX October 18th 2019, 5:10pm |
|
@StockTexts $EGRX Eagle Pharmaceuticals, Inc. SEC Filing: Form 4 https://t.co/q4fvAjNr9E October 18th 2019, 5:10pm |
|
@IRAMarketReport Eagle Pharmaceuticals $EGRX Lowered to “Strong Sell” at Zacks Investment Research https://t.co/68ZsDjtBuf #markets October 18th 2019, 4:10pm |
|
@chaffeybreeze Eagle Pharmaceuticals $EGRX Lowered to “Strong Sell” at Zacks Investment Research https://t.co/qNtyUh8FRL #stocks October 18th 2019, 4:10pm |
|
@ConsumerFeed Eagle Pharmaceuticals $EGRX Lowered to “Strong Sell” at Zacks Investment Research https://t.co/yy7hRAcoIH October 18th 2019, 4:10pm |
 |
@StockflareUS $EGRX: Forecast sales for Eagle Pharmaceuticals Inc are no longer forecast to rise this year. (https://t.co/usXBzDCBU1) October 18th 2019, 6:10am |
|
@AmericanBanking Equities Analysts Set Expectations for Eagle Pharmaceuticals Inc’s Q3 2019 Earnings $EGRX https://t.co/XkYRx1MOas #stocks October 18th 2019, 6:10am |
 |
@TickerReport Eagle Pharmaceuticals $EGRX Upgraded at Zacks Investment Research https://t.co/oo0YZjlqTL October 18th 2019, 5:10am |
 |
@OlympiaReport Eagle Pharmaceuticals Inc $EGRX Director Sells $244,820.67 in Stock https://t.co/cys8uPNUmW October 18th 2019, 4:10am |
|
@WeekHerald Eagle Pharmaceuticals Inc $EGRX Director Hudson Executive Capital Lp Sells 3,909 Shares https://t.co/ujnicZ9BN9 October 18th 2019, 4:10am |
|
@stocknewstimes Insider Selling: Eagle Pharmaceuticals Inc $EGRX Director Sells $470,992.64 in Stock https://t.co/YLxEHO9iax October 18th 2019, 4:10am |
 |
@TranscriptDaily Hudson Executive Capital Lp Sells 7,829 Shares of Eagle Pharmaceuticals Inc $EGRX Stock https://t.co/gxsEJR2qRu October 18th 2019, 4:10am |
|
@ZolmaxNews Eagle Pharmaceuticals $EGRX Downgraded to Strong Sell at Zacks Investment Research https://t.co/Dp60x1znkq October 17th 2019, 10:10pm |
|
@Tickeron $EGRX's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram crosses above signal line. View odds for… https://t.co/JKTtBqTrCJ October 17th 2019, 9:10pm |
 |
@SwingTradeBot New 52 Week High today: $EGRX ... https://t.co/4Iw0QeR3p8 October 17th 2019, 10:10am |
|
@ThisLincolnian Eagle Pharmaceuticals $EGRX Upgraded at Zacks Investment Research https://t.co/jbRQeTIqh3 October 17th 2019, 7:10am |
|
@dailypoliticaln Eagle Pharmaceuticals Inc $EGRX Director Sells $244,820.67 in Stock https://t.co/eq0tDacJ1J October 17th 2019, 4:10am |
|
@TickerReport Hudson Executive Capital Lp Sells 3,909 Shares of Eagle Pharmaceuticals Inc $EGRX Stock https://t.co/bCI02srdX0 October 17th 2019, 4:10am |
 |
@WatchlistN Eagle Pharmaceuticals $EGRX Reaches New 52-Week High at $62.68 https://t.co/yD3ifRCSma October 17th 2019, 4:10am |
 |
@EnterpriseLeade Hudson Executive Capital Lp Sells 7,829 Shares of Eagle Pharmaceuticals Inc $EGRX Stock https://t.co/ndWqGKN8sw October 17th 2019, 4:10am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.